AOP Orphan Pharmaceuticals AG

Founded

1996

Staff

174

Organization type

RDM biotech/pharma

Region

Vienna

Cluster

LISAvienna

Focus

human health

AOP Orphan Pharmaceuticals AG is an international pharmaceutical company with a focus on rare and special diseases. Over the past 25 years, the company has become an established provider of integrated therapy solutions from its headquarters in Vienna. This has been made possible by a high level of investment in research and development and a strong orientation towards the needs of especially the patients and their families but also the doctors and health care professionals.

R&D:AOP Orphan is a pharmaceutical company that invests a large part of its annual turnover in the research and development. The company focuses on rare diseases, also known as orphan diseases. As a fully integrated pharmaceutical company, AOP Orphan’s scope of activities includes preclinical research

Production:AOP Orphan operates with a global network of Contract Manufacturing Organizations (CMOs) to develop new pharmaceutical drugs and to ensure continuous supply. AOP develops the Clinical Trial Material for its Research and Development activities and establishes the production and testing processes with its CMOs for the commercial supply. AOP manages the entire supply with numerous partners around the globe and constantly strives to implement highest standards in drug development and production.

Services:The AOP Orphan Group’s portfolio contains over 30 drugs as well as patient services and medical products in four indication areas: hemato-oncology, cardiology